The authors would like to draw the reader\'s attention to errors in the following article:

Kondo N, Tsukuda M, Taguchi T, Nakazaki K, Sakakibara A, Takahashi H, Toth G, Nishimura G. Gene status of head and neck squamous cell carcinoma cell lines and cetuximab-mediated biological activities. *Cancer Sci* 2011; **102**: 1717--1723.

The relevance of the findings reported in the article on mutation status of *PIK3CA, PTEN, KRAS* and *BRAF*, and correlation between expression levels of epidermal growth factor receptor (EGFR) and cetuximab-mediated antibody-dependent cell-mediated-cytotoxicity (ADCC) published in September 2011 is now in question. The research reported was conducted on 16 cell lines that the authors believed to be head and neck squamous cell carcinoma (HNSCC) cell lines. Because different human leukocyte antigen (HLA) was detected in 2 cell lines (KCC-TCM901 and KCC-T873) which were derived from the same patient in an experiment after publication, 16 cell lines were analyzed by short tandem repeat (STR) analysis. STR analysis revealed that genotype of KCC-TCM901, YCU-H891 and KCC-MS871 was identical or highly similar to that of HeLa cells, and genotype of YCU-T891 was identical to that of KCC-L891 which was considered to be cross-contamination.

The authors apologizes for this error and any confusion it may have caused.
